ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity - Liz, M.A.; Gomes, C.M.; Saraiva, M.J.; Sousa, M.M. (Journal of Lipid Research, 2007)